Home › NDC Lookup › RxCUI directory › RxCUI 1792377

Lenvatinib 4 MG Oral Capsule [Lenvima] — RxCUI 1792377

RxNorm drug concept · Semantic branded drug
RxCUI 1792377 Semantic branded drug · SBD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1792377
Official nameLenvatinib 4 MG Oral Capsule [Lenvima]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLenvima 4 MG Oral Capsule
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)2,968 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Lenvatinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Lenvima is approved for four types of cancer in adults. It treats differentiated thyroid cancer that no longer responds to radioactive iodine, unresectable liver cancer (hepatocell...
  • What cancers does Lenvima actually treat?
  • The most important thing is consistency — pick a time that works for you and stick to it every day. You can take Lenvima with or without food, so that's flexible. If you do eat a h...
  • Does it matter what time of day I take it, or whether I take it with food?
📖 Read our full Lenvatinib guide →

🕸️ Concept Web — How Lenvatinib 4 MG Oral Capsule [Lenvima] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Lenvatinib 4 MG Oral Capsule [Lenvima] RxCUI 1792377

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Lenvatinib 1603296
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lenvima 1792372
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Lenvatinib Oral Capsule 1604344
    • Lenvatinib Oral Product 1604342
    • Lenvatinib Pill 1604343
    • Lenvatinib Oral Capsule [Lenvima] 1792374
    • Lenvima Oral Product 1792375
    • Lenvima Pill 1792376
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 12

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 21 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

8 products · 8 package NDCs
8 package NDCs map to RxCUI 1792377 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
62856-0704-30 6 BLISTER PACK in 1 BOX, UNIT-DOSE (62856-704-30) / 5 CAPSU... Lenvima Eisai Inc. 2018-08-15
62856-0708-30 6 BLISTER PACK in 1 BOX, UNIT-DOSE (62856-708-30) / 10 CAPS... Lenvima Eisai Inc. 2016-05-13
62856-0710-30 6 BLISTER PACK in 1 BOX, UNIT-DOSE (62856-710-30) / 5 CAPSU... Lenvima Eisai Inc. 2015-02-13
62856-0712-30 6 BLISTER PACK in 1 BOX, UNIT-DOSE (62856-712-30) / 15 CAPS... Lenvima Eisai Inc. 2018-08-15
62856-0714-30 6 BLISTER PACK in 1 BOX (62856-714-30) / 1 KIT in 1 BLISTER... Lenvima Eisai Inc. 2015-02-13
62856-0718-30 6 BLISTER PACK in 1 BOX (62856-718-30) / 1 KIT in 1 BLISTER... Lenvima Eisai Inc. 2016-05-13
62856-0720-30 6 BLISTER PACK in 1 BOX, UNIT-DOSE (62856-720-30) / 10 CAPS... Lenvima Eisai Inc. 2015-02-13
62856-0724-30 6 BLISTER PACK in 1 BOX (62856-724-30) / 1 KIT in 1 BLISTER... Lenvima Eisai Inc. 2015-02-13
Observed labelers: Eisai Inc. (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.